Botanical and Plant-Derived Drugs Market Analysis Asia, Europe, North America, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Feb 2024 Pages: 177 SKU: IRTNTR45751

Botanical and Plant-Derived Drugs Market Forecast 2024-2028

The global botanical and plant-derived drugs market size is estimated to grow by USD 20.93 billion, at a CAGR of 8.18% between 2023 and 2028. It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

Government initiatives worldwide are driving the development of plant-based drugs, with global healthcare systems increasingly embracing herbal medicines. In countries like China, India, Nigeria, and the US, as well as organizations like WHO, significant R&D investments are being made. Governments incentivize industry players to invest in plant-based drug R&D through contracts and grants. For instance, PlantForm, under a Government of Canada contract, is developing a plant-based antibody for ricin exposure. Similarly, the College of Pharmacy in Chicago is researching botanical dietary supplements' safety and efficacy for women's health with NIH grants. Hence such factors will have a positive impact on the market during the forecast period.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Type, Application, and Geography Analysis

Type Analysis

The market share by the oral segment will be significant during the forecast period. The oral segment of the market includes tablets, capsules, oral solutions, and liquid concentrates. Oral solutions are one of the most versatile, easy-to-administer, and fast-absorbing drug types in the market. They are used by consumers and healthcare providers alike and are available in a variety of forms, from tinctures to syrups to extracts to liquid concentrates. 

Get a glance at the market contribution of various segments Download PDF Sample

The oral segment was valued at USD 13.88 billion in 2018. Additionally, Bayer AG offers Iberogast oral liquid for abdominal pain and cramps, chronic constipation, nausea, and vomiting. Likewise, the benefits of capsules and tablets in botanical drug delivery include standardized and controlled dosage. Consistent efficacy and safety. Easy-to-use and convenient dosage forms. Improved patient compliance. No need to measure or prepare complex formulations. Major market players like Bayer AG, Jazz Pharmaceuticals Plc, Pierre Fabre SA, and Jaguar Health Inc. are offering botanical drugs in the form of capsules and tablets in the market. Thus, such factors under the oral segment will drive the evolution of the market during the forecast period.

Application Analysis

The infectious diseases segment is the largest segment as per type in the market during the forecast period. The increasing prevalence of infectious diseases like hepatitis, influenza, and human immunodeficiency virus (HIV) will increase demand for this segment. Infectious diseases or communicable diseases spread from person to person through indirect or direct contact and are caused by pathogens such as bacteria, viruses, fungi, and parasites. For treatment, patients must consume drugs that are anti-infective in nature. Hence, such factors will propel the market growth of this segment during the forecast period.

The central nervous system segment is expected to grow significantly in the market during the forecast period. The central nervous system consists of the brain and spinal cord and helps in the proper functioning of all body parts. However, autoimmune and inflammatory diseases, neurodegenerative diseases, cancers, genetic disorders, etc., affect the structure and function of the brain or spinal cord. Plant-derived drugs are considered the best means of treatment for such illnesses, which will drive further segment growth during the forecast period 

Regional Analysis

For more insights about the market share of various regions Download the PDF Sample now!

Asia is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The APAC region is the largest regional market due to the availability of a wide range of plant species with India having around 45,000 plant species. A few of them have medicinal properties such as antihistaminic, antiasthmatic, and antiallergic activities.

Furthermore, in China, the government, consumers, and healthcare professionals consider traditional Chinese medicine to be at par with Western medical science. Additionally, in India, various factors such as greater awareness of herbal drugs and medicinal plants and increased research expenditure are driving the market growth of the plant-based drugs market. Hence market players are launching new, more affordable products. Therefore, such factors will propel the market growth during the forecast period

Buy the Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Bausch Health Companies Inc.: The company offers botanical and plant derived drugs, such as Targretin gel used to treat skin problems arising from a disease called cutaneous T-cell lymphoma.

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Devonian Health Group Inc.
  • Dr. Willmar Schwabe GmbH and Co. KG
  • F. Hoffmann La Roche Ltd.
  • Hetero Labs Ltd.
  • Jaguar Health Inc.
  • Jazz Pharmaceuticals Plc
  • Medigene AG
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Pierre Fabre SA
  • Protalix Biotherapeutics Inc.
  • Wilson Drugs and Pharmaceuticals Pvt. Ltd.
  • Zea Biosciences Corp
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Drivers

Growing demand for effective treatment of chronic disorders is the key factor driving the market. Globally, chronic diseases such as cardiovascular disease, diabetes, and cancer are on the rise. These diseases often require chronic and long-term treatment, making intravenous therapy an essential part of patient care. Chronic diseases are increasing due to factors such as sedentary lifestyle, poor diet, and aging populations. There is a growing demand for effective and reliable plant-derived drug delivery methods, drugs, nutrients, and fluids directly to the bloodstream.

Additionally, the growing demand for the effective treatment of chronic disorders such as epilepsy will drive global botanical and plant-derived drug market growth during the forecast period. Further, as there are high unmet needs in the market, the vendors are increasingly focusing on providing plant-based drugs as an alternative to conventional drugs. Thus, such factors will drive the growth of the market during the forecast period.

Significant Trends

The transformation of the regulatory landscape in the US is a key trend in the market. Align with market trends and analysis, the increasing development of botanical drugs is resulting in market expansion. For example, the US FDA created a pathway for market players to get their botanical drugs approved in 2004 and received 400 IND applications. One was approved in 2012, while the second, Fulyzaq by Salix Pharmaceuticals, was approved for diarrhea treatment in HIV/AIDS patients who are undergoing antiretroviral therapy. 

Moreover, this side effect of antiretroviral therapy has resulted in many discontinuing it, and there is also no alternative US FDA-approved treatment for it. In August 2015, the US FDA revised its 2004 guidance for botanical drug development, giving emphasis to the European Medicines Agency Good Agriculture and Collection Practices (EMA GACPs) and the WHO GACPs for medicinal plants. Hence a dynamic regulatory and compliance landscape is expected to propel market development during the forecast period.

Major Challenges

The low acceptance among physicians is challenging market expansion. Despite further advances in the development of plant-derived drugs, end users, especially physicians, are resisting the use of such drugs due to efficacy concerns. They raise safety concerns regarding some plant-derived drugs. For example, in April 2016, an article published in the Lancet - Diabetes and Endocrinology created a controversy related to alternative medicine therapy for diabetes treatment. 

Additionally, it questioned the safety of Ayurvedic drugs due to concerns such as increasing metal toxicity in such drugs. Nearly one-fifth of Ayurvedic drugs manufactured in India and the US exceed the daily intake of mercury, lead, or arsenic compounds, according to one of the studies it cites. Moreover, such drugs are not regulated and are easy to obtain, resulting in several physicians warning against the usage of herbal medicines for diabetes treatment. Hence, such factors will impede market development during the forecast period. 

Buy Now Full Report

Market Customer Landscape

The market growth analysis report includes the adoption lifecycle of the market growth and forecasting, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market research and growth by revenue at global, regional & country levels and provides an analysis of the latest market growth and trends opportunities from 2018 to 2028. 

  • Type Outlook
    • Oral
    • Injectables
    • Topicals
  • Application Outlook
    • Infectious diseases
    • Central nervous system
    • Cardiovascular diseases
    • Respiratory diseases
    • Digestive diseases and others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Market Analyst Overview: 

In the market, botanical and plant-derived drugs offer a diverse array of therapeutic options sourced from nature, including algae, microscopic fungi, and vegetable material. These substances hold promise in treating various ailments, from central nervous system disorders to chronic pain. Compounds like terpenes and steroids are found in plants and are key ingredients in many medications, including those derived from glycosides, morphine alkaloids, and ergot alkaloids. Market trends indicate a rise in demand for specialty drugs and a focus on pharmacologic methods for conditions such as lung cancer.

Regulatory bodies like the World Health Organization (WHO) and the Australian Government oversee the approval of botanical drugs and enforce laws and regulations regarding manufacturing and distribution. Despite occasional drug recalls, ongoing research and development ensure a steady stream of new products to meet market needs, including innovations like medicinal cannabis amidst debates over marijuana legalization. One notable example is Mytesi, an antidiarrheal derived from botanical sources, which highlights the potential of plant-based remedies in modern medicine. 

Botanical and Plant-Derived Drugs Market Scope

Report Coverage

Details

Page number

177

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 8.18%

Market Growth 2024-2028

USD 20.93 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

7.68

Regional analysis

Asia, Europe, North America, and Rest of World (ROW)

Performing market contribution

Asia at 44%

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Devonian Health Group Inc., Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., Hetero Labs Ltd., Jaguar Health Inc., Jazz Pharmaceuticals Plc, Medigene AG, Merck KGaA, Novartis AG, Pfizer Inc., Pierre Fabre SA, Protalix Biotherapeutics Inc., Riaan Wellness Pvt. Ltd., Wilson Drugs and Pharmaceuticals Pvt. Ltd., Zea Biosciences Corp, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download the Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the between 2024 and 2028
  • Precise estimation of the size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across Asia, Europe, North America, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global botanical and plant-derived drugs market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global botanical and plant-derived drugs market 2018 - 2022 ($ billion)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.3 Application Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Oral - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
    • 6.4 Injectables - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Injectables - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Injectables - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Injectables - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
    • 6.5 Topicals - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Topicals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Topicals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Topicals - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Type
      • Exhibit 46: Market opportunity by Type ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Type ($ billion)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 48: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on Application - Market share 2023-2028 (%)
    • 7.2 Comparison by Application
      • Exhibit 50: Chart on Comparison by Application
      • Exhibit 51: Data Table on Comparison by Application
    • 7.3 Infectious diseases - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
    • 7.4 Central nervous system - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Central nervous system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Central nervous system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Central nervous system - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Central nervous system - Year-over-year growth 2023-2028 (%)
    • 7.5 Cardiovascular diseases - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
    • 7.6 Respiratory diseases - Market size and forecast 2023-2028
      • Exhibit 64: Chart on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Data Table on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 66: Chart on Respiratory diseases - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on Respiratory diseases - Year-over-year growth 2023-2028 (%)
    • 7.7 Digestive diseases and others - Market size and forecast 2023-2028
      • Exhibit 68: Chart on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Data Table on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 70: Chart on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
      • Exhibit 71: Data Table on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
    • 7.8 Market opportunity by Application
      • Exhibit 72: Market opportunity by Application ($ billion)
      • Exhibit 73: Data Table on Market opportunity by Application ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 Asia - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 North America - Market size and forecast 2023-2028
      • Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ billion)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 Bausch Health Companies Inc.
              • Exhibit 123: Bausch Health Companies Inc. - Overview
              • Exhibit 124: Bausch Health Companies Inc. - Business segments
              • Exhibit 125: Bausch Health Companies Inc. - Key news
              • Exhibit 126: Bausch Health Companies Inc. - Key offerings
              • Exhibit 127: Bausch Health Companies Inc. - Segment focus
            • 12.4 Bayer AG
              • Exhibit 128: Bayer AG - Overview
              • Exhibit 129: Bayer AG - Business segments
              • Exhibit 130: Bayer AG - Key news
              • Exhibit 131: Bayer AG - Key offerings
              • Exhibit 132: Bayer AG - Segment focus
            • 12.5 Boehringer Ingelheim International GmbH
              • Exhibit 133: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 134: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 135: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 136: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 137: Boehringer Ingelheim International GmbH - Segment focus
            • 12.6 Devonian Health Group Inc.
              • Exhibit 138: Devonian Health Group Inc. - Overview
              • Exhibit 139: Devonian Health Group Inc. - Product / Service
              • Exhibit 140: Devonian Health Group Inc. - Key offerings
            • 12.7 Dr. Willmar Schwabe GmbH and Co. KG
              • Exhibit 141: Dr. Willmar Schwabe GmbH and Co. KG - Overview
              • Exhibit 142: Dr. Willmar Schwabe GmbH and Co. KG - Product / Service
              • Exhibit 143: Dr. Willmar Schwabe GmbH and Co. KG - Key offerings
            • 12.8 F. Hoffmann La Roche Ltd.
              • Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.9 Jaguar Health Inc.
              • Exhibit 149: Jaguar Health Inc. - Overview
              • Exhibit 150: Jaguar Health Inc. - Business segments
              • Exhibit 151: Jaguar Health Inc. - Key offerings
              • Exhibit 152: Jaguar Health Inc. - Segment focus
            • 12.10 Jazz Pharmaceuticals Plc
              • Exhibit 153: Jazz Pharmaceuticals Plc - Overview
              • Exhibit 154: Jazz Pharmaceuticals Plc - Product / Service
              • Exhibit 155: Jazz Pharmaceuticals Plc - Key news
              • Exhibit 156: Jazz Pharmaceuticals Plc - Key offerings
            • 12.11 Merck KGaA
              • Exhibit 157: Merck KGaA - Overview
              • Exhibit 158: Merck KGaA - Business segments
              • Exhibit 159: Merck KGaA - Key news
              • Exhibit 160: Merck KGaA - Key offerings
              • Exhibit 161: Merck KGaA - Segment focus
            • 12.12 Novartis AG
              • Exhibit 162: Novartis AG - Overview
              • Exhibit 163: Novartis AG - Business segments
              • Exhibit 164: Novartis AG - Key offerings
              • Exhibit 165: Novartis AG - Segment focus
            • 12.13 Pfizer Inc.
              • Exhibit 166: Pfizer Inc. - Overview
              • Exhibit 167: Pfizer Inc. - Product / Service
              • Exhibit 168: Pfizer Inc. - Key news
              • Exhibit 169: Pfizer Inc. - Key offerings
            • 12.14 Pierre Fabre SA
              • Exhibit 170: Pierre Fabre SA - Overview
              • Exhibit 171: Pierre Fabre SA - Business segments
              • Exhibit 172: Pierre Fabre SA - Key offerings
              • Exhibit 173: Pierre Fabre SA - Segment focus
            • 12.15 Protalix Biotherapeutics Inc.
              • Exhibit 174: Protalix Biotherapeutics Inc. - Overview
              • Exhibit 175: Protalix Biotherapeutics Inc. - Product / Service
              • Exhibit 176: Protalix Biotherapeutics Inc. - Key offerings
            • 12.16 Sanofi SA
              • Exhibit 177: Sanofi SA - Overview
              • Exhibit 178: Sanofi SA - Business segments
              • Exhibit 179: Sanofi SA - Key news
              • Exhibit 180: Sanofi SA - Key offerings
              • Exhibit 181: Sanofi SA - Segment focus
            • 12.17 Sun Pharmaceutical Industries Ltd.
              • Exhibit 182: Sun Pharmaceutical Industries Ltd. - Overview
              • Exhibit 183: Sun Pharmaceutical Industries Ltd. - Product / Service
              • Exhibit 184: Sun Pharmaceutical Industries Ltd. - Key news
              • Exhibit 185: Sun Pharmaceutical Industries Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 186: Inclusions checklist
                • Exhibit 187: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 188: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 189: Research methodology
                • Exhibit 190: Validation techniques employed for market sizing
                • Exhibit 191: Information sources
              • 13.5 List of abbreviations
                • Exhibit 192: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              botanical and plant-derived drugs market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis